Akcea Therapeutics, Inc. Deferred Tax Liabilities, Net
Akcea Therapeutics, Inc. had Deferred Tax Liabilities, Net of $3.31 million as of 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2020-03-02
- 2019-12-31: Deferred Tax Liabilities, Net $3.31M.
- 2018-12-31: Deferred Tax Liabilities, Net $811.00K.
- 2017-12-31: Deferred Tax Liabilities, Net $125.00K.
- 2016-12-31: Deferred Tax Liabilities, Net $281.00K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2019-12-31 | $3.31M 10-K · filed 2020-03-02 |
| 2018-12-31 | $811.00K 10-K · filed 2020-03-02 |
| 2017-12-31 | $125.00K 10-K · filed 2019-03-01 |
| 2016-12-31 | $281.00K 10-K · filed 2018-02-28 |